Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Homology Medicines
44 Hartwell Ave.
Lexington, MA 02421
Phone: 781-457-6128
http://www.homologymedicines.com/

Homology is a genetic medicines company translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The combination of a management team that has successfully developed and commercialized rare disease therapies, and a new multidimensional technology platform uniquely positions the Company to move beyond the current limitations of gene therapy and editing approaches to improve patient care. Homology Medicines has built foundational intellectual property on gene editing and gene therapy using vectors derived from naturally occurring human adeno-associated viruses (AAVs). The Company's technology is precise, on-target and highly efficient for in vivo editing of genetic mutations. The unique team and technology create a significant opportunity for Homology to rapidly advance a diverse pipeline of new medicines that address and potentially cure the underlying cause of genetic diseases.

Key Contact
Name
Arthur Tzianabos
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/02/16 $43,500,000 Series A 5AM Ventures
ARCH Venture Partners
Deerfield Management Company, L.P.
Temasek
undisclosed
08/01/17 $83,500,000 Series B 5AM Ventures
Alexandria Venture Investments
ARCH Venture Partners
Deerfield Management Company, L.P.
Fidelity Management & Research Company
HBM Healthcare Investments
Maverick Ventures
Novartis
Rock Springs Capital
Temasek
Vida Ventures
Vivo Capital
undisclosed